Jiang brings extensive knowledge of arbitration law and rules to the Beijing office, focusing on commercial dispute resolution. After serving at the Shanghai branches of the China International Economic and Trade Arbitration Commission (CIETAC) as deputy secretary and the China Maritime Arbitration Commission (CMAC) as secretary-general, Jiang joined Hui Zhong Law Firm as a partner. She later became a partner and head of arbitration at TianTong in 2021.
She is also an arbitrator for institutions, including the CIETAC, the CMAC, the Shanghai International Economic and Trade Arbitration Commission, the Shenzhen Court of International Arbitration, and the Hong Kong International Arbitration Centre. She is also an executive director of the China Academy of Arbitration Law and a member of the Belt and Road Committee of the International Chamber of Commerce.
Nicole Gong – who joined the firm at the same time as Jiang and formerly a partner at TianTong – will be based at the Shanghai office. Gong specialises in domestic and international dispute resolution, and has six years of experience at the CIETAC, handling cases in the areas of investment and financing, M&A, intellectual property licensing, and the sale and purchase of goods.
Two more new partners, Huang Lijun and Wang Aohan, bring their expertise from King & Wood Mallesons to the Shanghai office. As qualified patent agents, their primary focus lies in IP rights and related dispute resolution. They possess experience in managing trade secret and patent infringement lawsuits, standard essential patents, freedom to operate risks, and the establishment of robust IP rights and trade secret systems.
Prior to Huang practising as an attorney, she had a background as a scientific researcher at the Beijing Chest Hospital of the Capital Medical University. She also worked at the China National Intellectual Property Administration, the Shanghai Intellectual Property Court, and had a role as senior business development (BD) manager at Hansoh Pharmaceutical Group, which gave her a deep understanding of the life sciences and healthcare industries, particularly in handling the increase in pharmaceutical BD transactions in recent years.
Wang has leverage in the materials, new energy, electronics and telecommunications, and semiconductors sectors. Wang currently serves as an expert for the China Association for Science and Technology in energy and chemicals.
Partner Liao Sufang, formerly a partner at SD & Partners, will join the Shenzhen office. She specialises in dispute resolution, debt restructuring, insolvency and bankruptcy, corporate and M&A, and has handled many contractual disputes involving equity transfers, shortfalls, asset management, share pledged repurchase transactions, bond pledge agreements, and financial borrowings.